Bevasiranib sodium is a small interfering RNA (siRNA) therapeutic designed to treat ocular diseases, particularly age-related macular degeneration (AMD). By targeting and silencing the mRNA for vascular endothelial growth factor (VEGF), bevasiranib sodium aims to inhibit the production of VEGF, a key protein involved in the formation of abnormal blood vessels and increased vascular permeability in the retina, which are characteristic of AMD.
Chemical Structure:
BOC Sciences is a leading provider of DNA and RNA products and services that meet the needs of researchers and pharmaceutical companies worldwide. Its broad product portfolio includes various types of oligonucleotides, DNA/RNA synthesis feedstocks, RNA interference tools, and advanced drug delivery systems, among others. Designed to promote cutting-edge research and innovative therapeutic solutions, at BOC Sciences you are sure to find the right product for you.